Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience

被引:3
作者
Kim, Jong Man [1 ]
Lee, Kwang-Woong [2 ]
Sinn, Dong-Hyun [3 ]
Choi, Gyu-Seong [1 ]
Yi, Nam-Joon [2 ]
Kwon, Choon Hyuck David [1 ]
Suh, Kyung-Suk [2 ]
Joh, Jae-Won [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Surg, 101 Daehak Ro, Seoul 03080, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Gastroenterol,Dept Med, Seoul, South Korea
关键词
Safety; Antiviral agents; Liver transplantation; Treatment outcome; PLUS RIBAVIRIN; HCV INFECTION; SOFOSBUVIR; MULTICENTER; RECURRENCE; THERAPY; PROGRAM;
D O I
10.4174/astr.2018.95.3.147
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: The proportion of liver recipients with HCV is gradually increasing in Korea. Limited data are available regarding the efficacy of direct antiviral agents (DAAs) in liver transplant recipients in Asia. We aimed to assess the efficacy and safety of DAAs in HCV-infected liver recipients in Korea. Methods: Forty HCV-infected patients from 2 centers received DAAs in the pretransplant or posttransplant period between May 2015 and November 2016. Results: DAA was administered in the pretransplant period in 6 patients and the posttransplant period in 34 patients. Dalastavir and asunaprevir (n = 2) and sofosbuvir/ledipasvir and ribvarin (n = 4) were used in the pretransplant period. HCV RNA was not detected before liver transplantation in all patients. Sustained virological response (SVR) at 12 and 24 weeks after liver transplantation was 100%. In the posttransplant period, 33 of 34 patients received sofosfovir-based therapy. SVR at 12 weeks in those patients was 94%. Recurrent virologic relapse developed in 2 patients because of HCC recurrence or treatment failure. Adverse events included anemia (n = 2) and abdominal discomfort (n = 1). Conclusion: DAAs are an effective and well-tolerated treatment for HCV-infected recipients in Korea.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 19 条
  • [1] Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation
    Berenguer, M.
    Palau, A.
    Aguilera, V.
    Rayon, J. -M.
    Juan, F. S.
    Prieto, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (03) : 679 - 687
  • [2] PHOENIX: A Randomized Controlled Trial of Peginterferon Alfa-2a Plus Ribavirin as a Prophylactic Treatment After Liver Transplantation for Hepatitis C Virus
    Bzowej, Natalie
    Nelson, David R.
    Terrault, Norah A.
    Everson, Gregory T.
    Teng, Lichen L.
    Prabhakar, Avinash
    Charlton, Michael R.
    [J]. LIVER TRANSPLANTATION, 2011, 17 (05) : 528 - 538
  • [3] Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
    Charlton, Michael
    Everson, Gregory T.
    Flamm, Steven L.
    Kumar, Princy
    Landis, Charles
    Brown, Robert S., Jr.
    Fried, Michael W.
    Terrault, Norah A.
    O'Leary, Jacqueline G.
    Vargas, Hugo E.
    Kuo, Alexander
    Schiff, Eugene
    Sulkowski, Mark S.
    Gilroy, Richard
    Watt, Kymberly D.
    Brown, Kimberly
    Kwo, Paul
    Pungpapong, Surakit
    Korenblat, Kevin M.
    Muir, Andrew J.
    Teperman, Lewis
    Fontana, Robert J.
    Denning, Jill
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brandt-Sarif, Theo
    Pang, Phillip S.
    McHutchison, John G.
    Reddy, K. Rajender
    Afdhal, Nezam
    [J]. GASTROENTEROLOGY, 2015, 149 (03) : 649 - 659
  • [4] Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
    Charlton, Michael
    Gane, Edward
    Manns, Michael P.
    Brown, Robert S., Jr.
    Curry, Michael P.
    Kwo, Paul Y.
    Fontana, Robert J.
    Gilroy, Richard
    Teperman, Lewis
    Muir, Andrew J.
    McHutchison, John G.
    Symonds, William T.
    Brainard, Diana
    Kirby, Brian
    Dvory-Sobol, Hadas
    Denning, Jill
    Arterburn, Sarah
    Samuel, Didier
    Forns, Xavier
    Terrault, Norah A.
    [J]. GASTROENTEROLOGY, 2015, 148 (01) : 108 - 117
  • [5] Perspectives on treating hepatitis C infection in the liver transplantation setting
    Chen, Tianyan
    Terrault, Norah A.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2016, 21 (02) : 111 - 119
  • [6] Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study
    Coilly, Audrey
    Fougerou-Leurent, Claire
    de Ledinghen, Victor
    Houssel-Debry, Pauline
    Duvoux, Christophe
    Di Martino, Vincent
    Radenne, Sylvie
    Kamar, Nassim
    D'Alteroche, Louis
    Leroy, Vincent
    Canva, Valerie
    Lebray, Pascal
    Moreno, Christophe
    Dumortier, Jerome
    Silvain, Christine
    Besch, Camille
    Perre, Philippe
    Botta-Fridlund, Danielle
    Anty, Rodolphe
    Francoz, Claire
    Aberge, Armando
    Debette-Gratien, Maryline
    Conti, Filomena
    Habersetzer, Francois
    Rohel, Alexandra
    Rossignol, Emilie
    Danjou, Helene
    Roque-Afonso, Anne-Marie
    Samuel, Didier
    Duclos-Vallee, Jean-Charles
    Pageaux, Georges-Philippe
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (04) : 711 - 718
  • [7] Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
    Curry, Michael P.
    Forns, Xavier
    Chung, Raymond T.
    Terrault, Norah A.
    Brown, Robert, Jr.
    Fenkel, Jonathan M.
    Gordon, Fredric
    O'Leary, Jacqueline
    Kuo, Alexander
    Schiano, Thomas
    Everson, Gregory
    Schiff, Eugene
    Befeler, Alex
    Gane, Edward
    Saab, Sammy
    McHutchison, John G.
    Subramanian, G. Mani
    Symonds, William T.
    Denning, Jill
    McNair, Lindsay
    Arterburn, Sarah
    Svarovskaia, Evguenia
    Moonka, Dilip
    Afdhal, Nezam
    [J]. GASTROENTEROLOGY, 2015, 148 (01) : 100 - U519
  • [8] Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation: Two-Center Experience
    Elfeki, Mohamed A.
    Abou Mrad, Rachel
    Esfeh, Jamak Modaresi
    Zein, Nizar N.
    Eghtesad, Bijan
    Zervos, Xaralambos
    Hanouneh, Ibrahim A.
    O'Shea, Robert
    Carey, William D.
    Alkhouri, Naim
    [J]. TRANSPLANTATION, 2017, 101 (05) : 996 - 1000
  • [9] Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience
    Faisal, Nabiha
    Bilodeau, Marc
    Aljudaibi, Bandar
    Hirsch, Geri
    Yoshida, Eric M.
    Hussaini, Trana
    Ghali, Maged P.
    Congly, Stephen E.
    Ma, Mang M.
    Leonard, Jennifer
    Cooper, Curtis
    Peltekian, Kevork
    Renner, Eberhard L.
    Lilly, Leslie B.
    [J]. TRANSPLANTATION, 2016, 100 (05) : 1059 - 1065
  • [10] Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
    Forns, Xavier
    Charlton, Michael
    Denning, Jill
    McHutchison, John G.
    Symonds, William T.
    Brainard, Diana
    Brandt-Sarif, Theo
    Chang, Paul
    Kivett, Valerie
    Castells, Lluis
    Prieto, Martin
    Fontana, Robert J.
    Baumert, Thomas F.
    Coilly, Audrey
    Carlota Londono, Maria
    Habersetzer, Francois
    [J]. HEPATOLOGY, 2015, 61 (05) : 1485 - 1494